Wells Fargo
HQL

Wells Fargo’s abrdn Life Sciences Investors HQL Stock Holding History

Wells Fargo’s Portfolio HQL Stock Details HQL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$33.5K Buy
2,057
+1,309
+175% +$21.9K ﹤0.01% 5586
2025
Q4 		$12.5K Sell
748
-399
-35% -$6.71K ﹤0.01% 5902
2025
Q3 		$17.8K Buy
1,147
+954
+494% +$13.1K ﹤0.01% 5824
2025
Q2 		$2.48K Sell
193
-4,307
-96% -$53.1K ﹤0.01% 6194
2025
Q1 		$57.1K Sell
4,500
-863
-16% -$11.7K ﹤0.01% 5355
2024
Q4 		$70.4K Sell
5,363
-7,605
-59% -$110K ﹤0.01% 5371
2024
Q3 		$196K Buy
12,968
+10,573
+441% +$160K ﹤0.01% 4595
2024
Q2 		$33.9K Buy
2,395
+1,381
+136% +$18.7K ﹤0.01% 5429
2024
Q1 		$13.8K Buy
1,014
+154
+18% +$2.13K ﹤0.01% 5667
2023
Q4 		$11.6K Sell
860
-8,875
-91% -$109K ﹤0.01% 5795
2023
Q3 		$121K Sell
9,735
-95,703
-91% -$1.26M ﹤0.01% 4666
2023
Q2 		$1.43M Sell
105,438
-19,641
-16% -$271K ﹤0.01% 3177
2023
Q1 		$1.74M Sell
125,079
-158,468
-56% -$2.27M ﹤0.01% 2984
2022
Q4 		$4.03M Sell
283,547
-54,933
-16% -$796K ﹤0.01% 2235
2022
Q3 		$4.62M Buy
338,480
+45,194
+15% +$675K ﹤0.01% 2055
2022
Q2 		$4.17M Buy
293,286
+12,222
+4% +$185K ﹤0.01% 2228
2022
Q1 		$4.65M Sell
281,064
-21,303
-7% -$367K ﹤0.01% 2513
2021
Q4 		$5.82M Sell
302,367
-41,275
-12% -$830K ﹤0.01% 2418
2021
Q3 		$7.15M Buy
343,642
+16,666
+5% +$357K ﹤0.01% 2515
2021
Q2 		$7.01M Sell
326,976
-77,818
-19% -$1.57M ﹤0.01% 2540
2021
Q1 		$7.98M Sell
404,794
-34,675
-8% -$715K ﹤0.01% 2390
2020
Q4 		$8.68M Buy
439,469
+153,643
+54% +$2.84M ﹤0.01% 2211
2020
Q3 		$5.03M Buy
285,826
+40,659
+17% +$728K ﹤0.01% 2502
2020
Q2 		$4.4M Sell
245,167
-9,989
-4% -$171K ﹤0.01% 2573
2020
Q1 		$3.82M Buy
255,156
+8,597
+3% +$141K ﹤0.01% 2458
2019
Q4 		$4.3M Buy
246,559
+4,491
+2% +$73.7K ﹤0.01% 2694
2019
Q3 		$3.66M Buy
242,068
+5,844
+2% +$93.6K ﹤0.01% 2819
2019
Q2 		$3.98M Sell
236,224
-6,493
-3% -$107K ﹤0.01% 2767
2019
Q1 		$4.16M Buy
242,717
+4,785
+2% +$82.6K ﹤0.01% 2729
2018
Q4 		$3.6M Sell
237,932
-8,511
-3% -$150K ﹤0.01% 2766
2018
Q3 		$5.03M Buy
246,443
+29,323
+14% +$583K ﹤0.01% 2644
2018
Q2 		$4.08M Buy
217,120
+16,334
+8% +$307K ﹤0.01% 2869
2018
Q1 		$3.86M Buy
200,786
+7,316
+4% +$147K ﹤0.01% 2845
2017
Q4 		$3.8M Buy
193,470
+867
+0.5% +$17.4K ﹤0.01% 2831
2017
Q3 		$4.14M Buy
192,603
+11,024
+6% +$234K ﹤0.01% 2694
2017
Q2 		$3.79M Sell
181,579
-9,413
-5% -$190K ﹤0.01% 2657
2017
Q1 		$3.7M Sell
190,992
-13,951
-7% -$258K ﹤0.01% 2682
2016
Q4 		$3.48M Buy
204,943
+7,744
+4% +$136K ﹤0.01% 2698
2016
Q3 		$3.69M Sell
197,199
-36,737
-16% -$692K ﹤0.01% 2489
2016
Q2 		$4.02M Buy
233,936
+410
+0.2% +$7.57K ﹤0.01% 2471
2016
Q1 		$4.19M Sell
233,526
-42,867
-16% -$778K ﹤0.01% 2424
2015
Q4 		$6.53M Sell
276,393
-15,441
-5% -$383K ﹤0.01% 2155
2015
Q3 		$6.57M Buy
291,834
+16,701
+6% +$468K ﹤0.01% 2114
2015
Q2 		$7.76M Sell
275,133
-1,019
-0.4% -$28.2K ﹤0.01% 2098
2015
Q1 		$7.61M Sell
276,152
-2,598
-0.9% -$70.8K ﹤0.01% 2090
2014
Q4 		$6.93M Sell
278,750
-13,660
-5% -$328K ﹤0.01% 2092
2014
Q3 		$6.46M Sell
292,410
-19,267
-6% -$418K ﹤0.01% 2102
2014
Q2 		$6.47M Buy
311,677
+126,249
+68% +$2.65M ﹤0.01% 2150
2014
Q1 		$4.03M Buy
185,428
+19,572
+12% +$436K ﹤0.01% 2475
2013
Q4 		$3.39M Buy
165,856
+5,381
+3% +$104K ﹤0.01% 2547
2013
Q3 		$3.09M Buy
160,475
+12,869
+9% +$246K ﹤0.01% 2561
2013
Q2 		$2.64M Buy
+147,606
New +$2.67M ﹤0.01% 2606

Other funds holding HQL

Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
SCM
Saba Capital Management New York $3.62B AUM 13% 1-Year Est. Return
PCM
Penserra Capital Management Orinda, California $8.52B AUM 37.76% 1-Year Est. Return
Raymond James Financial
Raymond James Financial St Petersburg, Florida $324B AUM 22.36% 1-Year Est. Return
LPL Financial
LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return
NIM
Needham Investment Management New York $1.96B AUM 101.23% 1-Year Est. Return
FHA
Flagship Harbor Advisors Boston, Massachusetts $2.27B AUM 18.34% 1-Year Est. Return
Allspring Global Investments
Allspring Global Investments Charlotte, North Carolina $59.7B AUM 29.08% 1-Year Est. Return
RCM
Rivernorth Capital Management West Palm Beach, Florida $2B AUM 0.66% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

Wells Fargo's HQL Position: Q1 2026 in Review

Wells Fargo increased its abrdn Life Sciences Investors (HQL) stake by 175% in Q1 2026, buying an estimated $21.9K and bringing the position to 2,057 shares worth $33.5K. The position accounts for ﹤0.01% of the portfolio, ranked #5586.

Wells Fargo first reported a position in HQL in Q2 2013 and has held it in 52 quarters since. The position peaked at $8.68M in Q4 2020. 86 funds tracked by Wall St. Rank hold HQL as of Q1 2026.

  • Wells Fargo held 2,057 shares of abrdn Life Sciences Investors worth $33.5K as of Q1 2026.
  • Wells Fargo bought 1,309 abrdn Life Sciences Investors shares in Q1 2026, an estimated $21.9K.
  • abrdn Life Sciences Investors made up ﹤0.01% of Wells Fargo's portfolio in Q1 2026, its #5586 holding.
  • Wells Fargo first reported a position in abrdn Life Sciences Investors in Q2 2013 and has held it in 52 quarters since.
  • Wells Fargo's abrdn Life Sciences Investors position peaked at $8.68M in Q4 2020.
  • 86 funds tracked by Wall St. Rank held abrdn Life Sciences Investors as of Q1 2026.

Based on Wells Fargo's 13F filing for Q1 2026, filed 11 May 2026.